COVID-19 Changed Healthcare Decision-Making. What Does It Mean for the U.S. Healthcare System? (Part 1)

Tuesday, March 23 at 1:00pm to 2:00pm

This is a past event.
Virtual Event

Day 1: COVID-19 Changed Patient Preferences For When, Where and How to Receive Care. Will These Trends Prove Durable Post-Pandemic, and What Do They Mean for Long-Term Health and Costs?

The COVID-19 pandemic has changed the way Americans make their healthcare decisions. Periods of high and rising cases have quickly pushed health systems past capacity, forcing providers to cancel non-COVID procedures. Furthermore, patients now recognize that physician visits and procedures that once seemed routine and mundane now carry the risk of exposure to a highly transmissible and dangerous disease. According to the CDC, 41% of U.S. adults have skipped care during the pandemic. We have yet to fully understand the long-term health and cost implications of this delayed or foregone care.

In response, health systems and policymakers have had to rethink how to provide and pay for care that patients value. For example, telehealth has become an acceptable and widespread alternative approach to patient care, and payers have stepped up to reimburse the service. But some healthcare must be delivered in-person, and patients want reassurance that they will be safe from infectious diseases, even after the current crisis is over. What steps need to be taken by public and private decision makers to equitably give patients what they want while also ensuring a health system able to meet the capacity demands of a future pandemic?

Join the Schaeffer Center for a two-part series on the pandemic’s effects on the kind of care patients are seeking, what they value and prefer, and the need for healthcare systems, payers, and policy makers to meet this challenge in an equitable way.

 

Panelists include: Erin Trish, Schaeffer Center Associate Director; Suzanne J. Baron, MD, MSc, Director of Interventional Cardiology Research, Lahey Hospital and Medical Center; Otis W. Brawley, MD, Bloomberg Distinguished Professor of Oncology and Epidemiology, Johns Hopkins University; Wändi Bruine de Bruin, MSc, PhD, Provost Professor of Public Policy, Psychology, and Behavioral Science, USC Price School of Public Policy; Emmett Keeler, PhD, Professor, Pardee RAND Graduate School

Event Type

Lecture / Talk / Workshop

Audience

Students, Alumni, Faculty/Staff

Campus

University Park Campus, Health Sciences Campus

Tags

academics

Website

https://healthpolicy.usc.edu/events/d...

Department
Price School of Public Policy, School of Pharmacy, USC Schaeffer Center
Add this to your calendar

Recent Activity